Search
for
Sort by
Research 331–360 of 1000+
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Janus kinase inhibitors for alopecia areata: A narrative review
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
- 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Treating Alopecia Areata: Current Practices Versus New Directions
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Alopecia areata
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- In reply
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part II Systemic Treatment